Obinutuzumab Intravenous and Sinemet CR 100/25
Determining the interaction of Obinutuzumab Intravenous and Sinemet CR 100/25 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: obinutuzumab
Brand name: Gazyva
Synonyms: Obinutuzumab
Generic Name: carbidopa / levodopa
Brand name: Parcopa, Rytary, Sinemet, Sinemet CR, Duopa
Synonyms: Carbidopa and levodopa, Carbidopa and Levodopa
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Obinutuzumab Intravenous-Sinemet CR 200/50
- Obinutuzumab Intravenous-Sinequan
- Obinutuzumab Intravenous-Sinequan (Doxepin Capsules)
- Obinutuzumab Intravenous-Sinequan (Doxepin Oral Concentrate)
- Obinutuzumab Intravenous-Sinex Long-Acting
- Obinutuzumab Intravenous-Sinex Nasal Spray
- Sinemet CR 100/25-Obizur
- Sinemet CR 100/25-Obizur Intravenous
- Sinemet CR 100/25-Obredon
- Sinemet CR 100/25-Ocaliva
- Sinemet CR 100/25-Occlucort
- Sinemet CR 100/25-Occlusal-HP Topical